4YL.F 1.22 (-3.17%)
FI4000330972BiotechnologyBiotechnology

Nanoform Finland (4YL.F) Stock Highlights

1.22 | -3.17%
2024-12-21 06:50:01
Nanoform Finland PLC is an nanoparticle medicine enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules formulation performance through its nanoforming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nanoformed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and by improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications.

Statistics

Range Today
1.22 1.22
Volume Today 0
Range 1 Year
1.08 3.06
Volume 1 Year 38.88K
Range 3 Year
1.08 7.13
Volume 3 Year 204.39K
Range 10 Year
1.08 8.66
Volume 10 Year 242.72K

Highlights

Market Capitalization 106.48M (small)
Floating Shares 62.56M
Current Price 1.22
Price To Earnings -4.24
Price To Revenue 22.8
Price To Book 1.38
Earnings Per Share -0.27
Payout Ratio 0%

Performance

Latest -3.17%
1 Month +4.27%
3 Months -24.22%
6 Months -28.24%
1 Year -22.29%
3 Years -80.88%
5 Years -72.4%
10 Years -72.4%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.